Find Reports
Select Report Type
Reimbursement Review
Displaying 1251 - 1258 of 1258
Health Technology Review
Displaying 576 - 589 of 589
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 40 of 40
View All Reports
Displaying 2051 - 2075 of 2093
Please scroll or swipe to the right to view the full content.
Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
---|---|---|---|---|---|---|---|
Niacin/lovastatin | Reimbursement Review | Complete | SR0042-000 | ||||
Insulin aspart/insulin aspart protamine | Reimbursement Review | Complete | SR0041-000 | ||||
Omalizumab | Reimbursement Review | Complete | SR0045-000 | ||||
Tenofovir disoproxil fumarate | Reimbursement Review | Complete | SR0040-000 | ||||
Escitalopram oxalate | Reimbursement Review | Withdrawn | SR0039-000 | ||||
Abacavir/lamivudine | Reimbursement Review | Complete | SR0038-000 | ||||
Erlotinib | Reimbursement Review | Complete | SR0037-000 | ||||
Pregabalin | Reimbursement Review | Complete | SR0036-000 | ||||
Omalizumab | Reimbursement Review | Cancelled | SR0035-000 | ||||
Mycophenolate sodium | Reimbursement Review | Complete | SR0034-000 | ||||
Insulin glargine (rDNA origin) | Reimbursement Review | Complete | SR0033-000 | ||||
Laronidase | Reimbursement Review | Complete | SR0032-000 | ||||
Atomoxetine hydrochloride | Reimbursement Review | Complete | SR0031-000 | ||||
Fosamprenavir calcium | Reimbursement Review | Complete | SR0030-000 | ||||
Drospirenone /ethinyl estradiol | Reimbursement Review | Complete | SR0029-000 | ||||
Memantine hydrochloride | Reimbursement Review | Complete | SR0025-000 | ||||
Quinagolide hydrochloride | Reimbursement Review | Complete | SR0026-000 | ||||
Mixed amphetamine salts | Reimbursement Review | Withdrawn | SR0027-000 | ||||
Agalsidase beta | Reimbursement Review | Complete | SR0028-000 | ||||
Alefacept | Reimbursement Review | Complete | SR0024-000 | ||||
Voriconazole | Reimbursement Review | Complete | SR0023-000 | ||||
Adalimumab | Reimbursement Review | Complete | SR0022-000 | ||||
Eletriptan hydrobromide | Reimbursement Review | Complete | SR0021-000 | ||||
Dutasteride | Reimbursement Review | Complete | SR0019-000 | ||||
Voriconazole | Reimbursement Review | Withdrawn | SR0020-000 |